Physician profile
Ryan Kuta
NPI 1851882278
$114,055.49
in general payments reported to CMS, 2019-2025
24 companies · $3,588 in 2025
The $3,588 reported for 2025 was more than what 91% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $288 · 2020: $21.15 · 2022: $99K · 2023: $9,039 · 2024: $2,273 · 2025: $3,588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,440 · Travel and Lodging: $5,407 · Grant: $52.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,439.80 |
| Travel and Lodging | $5,406.59 |
| Grant | $52.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $59,651.63 | 2019-2025 | Proclaim, Eterna, Prodigy |
| Boston Scientific Corporation | $27,556.48 | 2022-2025 | Superion Indirect Decompression System, Wavewriter Alpha Prime 16, General - Pain Management |
| Medtronic, INC. | $20,457.38 | 2022-2025 | Synchromedii, Intellis Adaptivestim |
| Nevro Corp. | $1,785.82 | 2022-2024 | Senza |
| Saluda Medical Americas, INC. | $1,397.00 | 2023-2025 | Evoke Scs, Evoke |
| Nalu Medical, INC. | $646.35 | 2022-2023 | Nalu Neurostimulation System |
| Mml US, INC. | $399.29 | 2024-2025 | Reactiv8 |
| Abbvie INC. | $381.35 | 2022-2025 | |
| Biotronik Nro, INC. | $320.12 | 2023-2025 | Prospera, Biotronik |
| Globus Medical, INC. | $214.97 | 2025 | Senza, Vyrsa V1 |
| Spr Therapeutics, INC | $211.02 | 2023 | Sprint Pns System |
| Vertos Medical, INC. | $168.09 | 2022-2024 | Mild Device Kit |
| Spinal Simplicity, LLC | $162.23 | 2023-2025 | Ha Minuteman G3-R |
| Vertiflex, INC. | $155.95 | 2019 | |
| Merz Pharmaceuticals, LLC | $125.00 | 2023 | Xeomin |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $114.45 | 2023 | Intracept |
| Grt US Holding, INC. | $95.42 | 2022 | |
| Collegium Pharmaceutical, INC. | $81.79 | 2022-2023 | Xtampza |
| Curonix LLC | $30.62 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Radius Health, INC. | $25.37 | 2025 | Tymlos |
| Avanos Medical | $23.71 | 2024 | Generator |
| Biohaven Pharmaceutical Holding Company Ltd. | $17.39 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $17.21 | 2025 | |
| Tersera Therapeutics LLC | $16.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Kuta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.